Exploring Causal Relationships between Circulating Inflammatory Proteins and Thromboangiitis Obliterans: A Mendelian Randomization Study
Bihui Zhang,Rui He,Ziping Yao,Pengyu Li,Guochen Niu,Ziguang Yan,Yinghua Zou,Xiaoqiang Tong,Min Yang
DOI: https://doi.org/10.1055/s-0044-1786809
2024-05-25
Thrombosis and Haemostasis
Abstract:Background Thromboangiitis obliterans (TAO) is a vascular condition characterized by poor prognosis and an unclear etiology. This study employs Mendelian randomization (MR) to investigate the causal impact of circulating inflammatory proteins on TAO. Methods In this MR analysis, summary statistics from a genome-wide association study meta-analysis of 91 inflammation-related proteins were integrated with independently sourced TAO data from the FinnGen consortium's R10 release. Methods such as inverse variance weighting, MR–Egger regression, weighted median approaches, MR-PRESSO, and multivariable MR (MVMR) analysis were utilized. Results The analysis indicated an association between higher levels of C–C motif chemokine 4 and a reduced risk of TAO, with an odds ratio (OR) of 0.44 (95% confidence interval [CI]: 0.29–0.67; p = 1.4 × 10 −4 ; adjusted p = 0.013). Similarly, glial cell line-derived neurotrophic factor exhibited a suggestively protective effect against TAO (OR: 0.43, 95% CI: 0.22–0.81; p = 0.010; adjusted p = 0.218). Conversely, higher levels of C–C motif chemokine 23 were suggestively linked to an increased risk of TAO (OR: 1.88, 95% CI: 1.21–2.93; p = 0.005; adjusted p = 0.218). The sensitivity analysis and MVMR revealed no evidence of heterogeneity or pleiotropy. Conclusion This study identifies C–C motif chemokine 4 and glial cell line-derived neurotrophic factor as potential protective biomarkers for TAO, whereas C–C motif chemokine 23 emerges as a suggestive risk marker. These findings elucidate potential causal relationships and highlight the significance of these proteins in the pathogenesis and prospective therapeutic strategies for TAO. The datasets analyzed during the current study are available in the EBI GWAS Catalog (accession numbers GCST90274758 to GCST90274848 and GCST90029014), https://www.ebi.ac.uk/gwas/, and the FinnGen repository (finngen_R10_I9_THROMBANG), https://www.finngen.fi/en/access_results. This research has been conducted using published studies and consortia providing publicly available summary statistics. All original studies have been approved by the corresponding ethical review board, and the participants have provided informed consent. In addition, no individual-level data were used in this study. Therefore, no new ethical review board approval was required Conception and design: M.Y. and B.Z. Administrative support: X.T. and Y.Z. Provision of study materials or patients: Z.Y. and G.N. Collection and assembly of data: B.Z., Z.Y., and R.H. Data analysis and interpretation: B.Z., R.H., and Z.Y. Manuscript writing: All authors. Final approval of manuscript: All authors. * These authors equally contributed to this paper and thus shared the co-first authorship. Received: 07 December 2023 Accepted: 05 April 2024 Article published online: 24 May 2024 © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/) Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
peripheral vascular disease,hematology